PG Procter & Gamble Company

P&G Appoints Nelson Peltz of Trian Partners to Board of Directors

The Procter & Gamble Company (NYSE:PG) today announced that it has appointed Nelson Peltz, Chief Executive Officer and a founding partner of Trian Fund Management, L.P., to its Board of Directors, effective March 1, 2018. The Company has also committed to re-nominate Mr. Peltz to the Board as part of the Company’s slate of nominees for the 2018 Annual Meeting of Shareholders.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005847/en/

Nelson Peltz, Chief Executive Officer and a founding partner of Trian Fund Management, L.P., is appo ...

Nelson Peltz, Chief Executive Officer and a founding partner of Trian Fund Management, L.P., is appointed to P&G’s Board of Directors, effective March 1, 2018. (Photo: Business Wire)

Mr. Peltz has been Chief Executive Officer of Trian Fund Management, L.P. since it was founded in November 2005. Mr. Peltz also serves as the non-executive Chairman of The Wendy’s Company. He is currently a director of Mondelēz International, Inc., Sysco Corporation, and The Madison Square Garden Company, and has previously served as a director of H. J. Heinz Company, Legg Mason, Inc., and Ingersoll-Rand plc.

“We respect Nelson Peltz as a highly engaged shareowner and investor, and look forward to his contributions as a member of P&G’s Board,” said David S. Taylor, P&G’s Chairman, President and Chief Executive Officer. “We have had constructive discussions with Nelson and we are committed to working together for the best interests of all P&G shareholders.”

“P&G is on the right track with its transformation,” said Lead Director Jim McNerney. “Nelson Peltz has more than 40 years of business and investment experience, and we welcome his input and the additional perspective he will bring to the boardroom.”

“P&G is a great company with tremendous potential,” said Nelson Peltz. “I am looking forward to working closely with David Taylor and the Board toward our shared goals of driving market share growth and improved margins to create more value for all P&G shareholders.”

From April 1993 through June 2007, Mr. Peltz served as Chairman and Chief Executive Officer of Triarc Companies, Inc. which during that period of time owned Arby's Restaurant Group, Inc. and the Snapple Beverage Group, as well as other consumer and industrial businesses. Mr. Peltz was Chairman and Chief Executive Officer and a Director of Triangle Industries, Inc. from 1983 until December 1988, the largest packaging company in the world and a Fortune 100 industrial company, when that company was acquired by Pechiney, S.A., a leading international metals and packaging company. Mr. Peltz began his business career in 1963 when he joined his family food business.

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands.

About Trian Fund Management, L.P.

Founded in 2005 by Nelson Peltz, Ed Garden and Peter May, Trian seeks to invest in high quality but undervalued public companies and to work constructively with the management and boards of those companies to significantly enhance shareholder value for all shareholders through a combination of improved operational execution, strategic redirection, more efficient capital allocation and increased focus.

EN
15/12/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Procter & Gamble Company

Moody's Ratings assigns Aa3 ratings to P&G's fixed rate USD notes

Moody's Ratings (Moody's) today assigned Aa3 ratings to the 5 year and 10 year senior unsecured fixed-rate USD notes offered by The Procter & Gamble Company ("P&G"). The proceeds will be used for general corporate purposes including debt refinancing. P&G's other ratings including the Aa3 senior unse...

Procter & Gamble Co: 1 director

A director at Procter & Gamble Co sold 18,000 shares at 171.660USD and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

MarketLine Department
  • MarketLine Department

Seventh Generation Inc - Company Profile and SWOT Analysis

Summary Seventh Generation Inc - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Seventh Generation Inc (Seventh Generation), a subsidiary of Unilever Plc, is a manufacturer and distributor of household and personal care products. The company's product portfolio includes kitc...

MarketLine Department
  • MarketLine Department

Oral Health Products Inc - Company Profile and SWOT Analysis

Summary Oral Health Products Inc - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Oral Health Products Inc (Oral Health Products) is a manufacturer and distributor of oral care products. The company's product portfolio includes toothbrush, disclosing tablets, dental floss, d...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch